Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for Silo Pharma (SILO) over the last 8 years, with Q3 2025 value amounting to $220312.0.

  • Silo Pharma's Non-Current Assets fell 2774.57% to $220312.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $220312.0, marking a year-over-year decrease of 2774.57%. This contributed to the annual value of $300360.0 for FY2024, which is 36221.32% up from last year.
  • As of Q3 2025, Silo Pharma's Non-Current Assets stood at $220312.0, which was down 2774.57% from $279476.0 recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's Non-Current Assets ranged from a high of $309464.0 in Q2 2024 and a low of $19375.0 during Q1 2021
  • For the 5-year period, Silo Pharma's Non-Current Assets averaged around $140542.7, with its median value being $88118.0 (2021).
  • In the last 5 years, Silo Pharma's Non-Current Assets surged by 40370.58% in 2022 and then plummeted by 5153.23% in 2023.
  • Silo Pharma's Non-Current Assets (Quarter) stood at $87869.0 in 2021, then decreased by 19.4% to $70821.0 in 2022, then dropped by 8.24% to $64983.0 in 2023, then skyrocketed by 362.21% to $300360.0 in 2024, then dropped by 26.65% to $220312.0 in 2025.
  • Its Non-Current Assets was $220312.0 in Q3 2025, compared to $279476.0 in Q2 2025 and $295808.0 in Q1 2025.